Hepatitis B surface antigen (HBsAg) prevalence (%) in Mongolia
Mongolia: Hepatitis B surface antigen (HBsAg) prevalence was 0.3% in 2024. ▼ Falling
Latest (2024)
0.3%
Change on year
down 25.0%
World rank
71st
of 194 countries
All-time high
0.5%
in 2015
All-time low
0.3%
in 2020
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Mongolia, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hepatitis b surface antigen (hbsag) prevalence in Mongolia stood at 0.3%. That is the lowest value across all 10 years on record.
That represents a change of down 25.0% on the previous year and down 40.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Mongolia peaked at 0.5% in 2015 and was at its lowest, 0.3%, in 2020.
That places Mongolia 71st out of 194 countries with data for 2024, putting it in the middle of the range.
Hepatitis B surface antigen (HBsAg) prevalence in Mongolia, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.5% | — |
| 2016 | 0.5% | +0.0% |
| 2017 | 0.4% | -20.0% |
| 2018 | 0.4% | +0.0% |
| 2019 | 0.4% | +0.0% |
| 2020 | 0.3% | -25.0% |
| 2021 | 0.3% | +0.0% |
| 2022 | 0.4% | +33.3% |
| 2023 | 0.4% | +0.0% |
| 2024 | 0.3% | -25.0% |
Mongolia compared with similar countries
- Mongolia's 0.3% is above the median for upper middle income countries, which is 0.2%, 1.5× the median. (57 countries reporting)
- Mongolia's 0.3% is below the median for East Asia & Pacific, which is 0.6%, 50% of the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.4% | 0.4% | 0.5% | 5 |
| 2020s | 0.3% | 0.3% | 0.4% | 5 |
Countries ranked near Mongolia
- 71 Turkmenistan 0.3% compare
- 71 Uganda 0.3% compare
- 71 Afghanistan 0.3% compare
- 71 Azerbaijan 0.3% compare
- 71 Bosnia and Herzegovina 0.3% compare
- 71 Haiti 0.3% compare
- 71 Sri Lanka 0.3% compare
- 71 Moldova 0.3% compare
- 71 Malawi 0.3% compare
- 71 Rwanda 0.3% compare
More health data for Mongolia
- Un projection of annual infant deaths, annual growth rate -1.56 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6056 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 847.3 deaths per 1,000 people (2090)
- Number of infants who die before age 1 63 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.44 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0458 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.5 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Mongolia?
- Hepatitis b surface antigen (hbsag) prevalence in Mongolia was 0.3% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Mongolia?
- The highest recorded value was 0.5% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Mongolia?
- The lowest recorded value was 0.3% in 2020.
- How does Mongolia rank for hepatitis b surface antigen (hbsag) prevalence?
- Mongolia ranks 71st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Mongolia?
- Over the last ten years it is down 40.0%. The long-run trend across the full record is falling.
- Where does this Mongolia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).